# Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)

> **NCT02903355** · PHASE3 · TERMINATED · sponsor: **Southern Illinois University** · enrollment: 351 (actual)

## Conditions studied

- Noise-induced Hearing Loss

## Interventions

- **DRUG:** D-methionine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02903355
- **Lead sponsor:** Southern Illinois University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2022-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02903355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02903355, "Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02903355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*